News
-
-
-
PRESS RELEASE
EsoCap announces publication of comprehensive Phase II results demonstrating ESO-101’s effectiveness in eosinophilic esophagitis
EsoCap AG announces Phase II results of ESO-101 for eosinophilic esophagitis treatment published in Alimentary Pharmacology & Therapeutics. Study shows safety, efficacy, and high patient satisfaction